News & Updates

Show Multimedia Only

Prophylactic intranasal IFN-α cuts COVID-19 incidence in cancer patients

20 May 2024 by

Prophylactic interferon-alpha (IFN-α) administered intranasally slashed the incidence of COVID-19 by almost half in a cohort of cancer patients in the C-SMART study.

Prophylactic intranasal IFN-α cuts COVID-19 incidence in cancer patients

20 May 2024

Inactivated vaccines help minimize COVID-19–associated pneumonia in RMDs

19 May 2024

In people with rheumatic and musculoskeletal diseases (RMDs), inactivated COVID-19 vaccines prove safe and effective at lowering the risk of COVID-19–related pneumonia, as shown in a study from China.

Inactivated vaccines help minimize COVID-19–associated pneumonia in RMDs

19 May 2024

Aspirin may offer protection against GI cancer-related death in H pylori-free individuals

18 May 2024

For people who have successfully undergone Helicobacter pylori-eradication therapy, the use of aspirin does more good than harm, such that the benefit of reduced gastrointestinal (GI) cancer-related mortality outweighs the risk of bleeding-related mortality, according to a study.

Aspirin may offer protection against GI cancer-related death in H pylori-free individuals

18 May 2024

HCV cure possible in people who inject drugs despite poor treatment adherence

17 May 2024

People who inject drugs (PWID) with low adherence to sofosbuvir/velpatasvir can still be cured of hepatitis C virus (HCV) infection, suggests a study.

HCV cure possible in people who inject drugs despite poor treatment adherence

17 May 2024

Novel device makes HIV detection possible in remote areas

17 May 2024 by

The portable micro-PCR accurately determines HIV-1 and HIV-2 viral loads at the same time and can be deployed in remote places where HIV quantification is not feasible, reports a study. This novel device measures HIV viral loads using a TruePrep extractor device for isolating RNA.

Novel device makes HIV detection possible in remote areas

17 May 2024

Long-term data strengthen TAK-003 potential against dengue

16 May 2024 by

The live-attenuated tetravalent dengue vaccine TAK-003 showed cumulative long-term efficacy in preventing symptomatic dengue caused by all four dengue virus (DENV) serotypes among previously exposed children and adolescents, and by DENV-1 and DENV-2 in dengue-naïve participants in eight* dengue-endemic countries, a study has shown.

Long-term data strengthen TAK-003 potential against dengue

16 May 2024

HbA1c variability linked to serious infections

16 May 2024

Fluctuations in HbA1c levels in between clinic visits may put individuals with type 2 diabetes (T2D) at increased risk of serious infections, according to a study.

HbA1c variability linked to serious infections

16 May 2024

Sequential fosfomycin therapy beneficial in bacterial prostatitis caused by multidrug-resistant E coli

14 May 2024 by

Sequential treatment with the oral antibiotic fosfomycin appears to be safe and effective in the management of patients with acute bacterial prostatitis secondary to multidrug-resistant Escherichia coli, according to the phase IV FOS-PROST study.

Sequential fosfomycin therapy beneficial in bacterial prostatitis caused by multidrug-resistant E coli

14 May 2024

Positive antibiotic interactions for MRSA bacteraemia tied to lower 14-day mortality

14 May 2024 by

Patients with positive in-vitro antibiotic interactions with vancomycin or daptomycin plus an antistaphylococcal β-lactam for methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia appear to have greater survival at 2 weeks, as shown in a post hoc analysis of the CAMERA-2* study.

Positive antibiotic interactions for MRSA bacteraemia tied to lower 14-day mortality

14 May 2024

Inappropriate pneumonia diagnosis common, potentially harmful for hospitalized older adults

14 May 2024

The frequency of inappropriate diagnosis of community acquired pneumonia (CAP) is relatively high among hospitalized adults, especially those who are older, have dementia, or present with altered mental status, according to a study. In such cases, a full-course antibiotic treatment may be detrimental.

Inappropriate pneumonia diagnosis common, potentially harmful for hospitalized older adults

14 May 2024

News & Updates

Filter by Specialty:

Specialty:

Prophylactic intranasal IFN-α cuts COVID-19 incidence in cancer patients

Prophylactic intranasal IFN-α cuts COVID-19 incidence in cancer patients

Inactivated vaccines help minimize COVID-19–associated pneumonia in RMDs

Inactivated vaccines help minimize COVID-19–associated pneumonia in RMDs

Aspirin may offer protection against GI cancer-related death in H pylori-free individuals

Aspirin may offer protection against GI cancer-related death in H pylori-free individuals

HCV cure possible in people who inject drugs despite poor treatment adherence

HCV cure possible in people who inject drugs despite poor treatment adherence

Novel device makes HIV detection possible in remote areas

Novel device makes HIV detection possible in remote areas

Long-term data strengthen TAK-003 potential against dengue

Long-term data strengthen TAK-003 potential against dengue

HbA1c variability linked to serious infections

HbA1c variability linked to serious infections

Sequential fosfomycin therapy beneficial in bacterial prostatitis caused by multidrug-resistant E coli

Sequential fosfomycin therapy beneficial in bacterial prostatitis caused by multidrug-resistant E coli

Positive antibiotic interactions for MRSA bacteraemia tied to lower 14-day mortality

Positive antibiotic interactions for MRSA bacteraemia tied to lower 14-day mortality

Inappropriate pneumonia diagnosis common, potentially harmful for hospitalized older adults

Inappropriate pneumonia diagnosis common, potentially harmful for hospitalized older adults